MedPath

Ganirelix in insemination cycles of women with premature luteinizatio

Phase 4
Completed
Conditions
infertility
intrauterine insemination
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
Registration Number
ACTRN12612000153819
Lead Sponsor
Mersin University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
114
Inclusion Criteria

The main inclusion criteria were age between 18 and 38 years, primary or secondary infertility lasting for > 12 months, normal thyroid function, normal prolactin levels and normal uterine cavity and bilateral tubal patency assessed by hysterosalpingography

Exclusion Criteria

severe male factor infertility (sperm concentration <10 x106 or strict morphology <4%), stage III or IVendometriosis, baseline FSH > 10 IU/L.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Two weeks after the intrauterine insemination procedure, an hCG assay was performed. If the assay was positive, transvaginal ultrasonography was scheduled for 2-3 weeks later. <br>Only a positive hCG was determined as biochemical pregnancy, both positive hCG assay and determination of embriyonic heartbeat was accepted as clinical pregnancy. Ultrasonography was done at 12-16th week to establish ongoing pregnancy.[two years period from June 2007<br>Two weeks after the intrauterine insemination procedure, an hCG assay was performed.<br>Ultrasonography was done at 12-16th week to establish ongoing pregnancy]
Secondary Outcome Measures
NameTimeMethod
uteinizing hormone (LH) levels > 10 IU/L and progesterone (PRG) levels > 1 ng/ml was considered as premature luteinization.<br>PRG level was determined by competitive electro-chemoluminescent immunoassay method by auto-analyzer. LH levels were determined by sandwich electro-chemoluminescent immunoassay method by the same autoanalyzer.[two years period from June 2007<br>LH and PRG levels were determined 10-14 days after menstruation]
© Copyright 2025. All Rights Reserved by MedPath